InsiderClue
← All stocks

Roivant Sciences Ltd.

ROIV Net selling
CIK 0001635088 #653 in the set updated 21 Sep 2026
Bought (120 mo)
$20.20M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.26B
$11.01M on a plan · $544.72M straight out of an exercise
Sold at will
$1.70B
164 of 292 sales
Net
−$2.24B
−$1.68B against sales at will

By person

21 insiders · 297 transactions
929×

Matthew Gline holds 929 times base salary in stock. $673.89M of shares against $725.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Gline last reported holding, valued at $40.45, the price Common Shares was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Gold Daniel Allen
Director
—
$341.57M (36)
−$341.57M
22,654,981
3.14%
$916.39M
−82.9%
QVT Financial LP entity
Director by Deputization
—
$300.69M (32)
−$300.69M
13,689,166
1.90%
$553.73M
−88.6%
MANCHESTER KEITH S
Director
—
$258.62M (30)
−$258.62M
15,442,623
2.14%
$624.65M
−81.0%
SVF Investments (UK) Ltd entity
10% owner
—
$242.63M (3)
−$242.63M
73,031,667
10.11%
$2.95B
−26.5%
Ramaswamy Vivek
10% owner
—
$224.96M (17)
−$224.96M
47,011,612
6.51%
$1.90B
−21.5%
Venker Eric
President & Immunovant CEO
—
$200.44M (90) scheduled
−$200.44M
1,599,154
0.2214%
$64.69M
+15.1%
Sumitomo Chemical Co., Ltd. entity
10% owner
—
$130.00M (1)
−$130.00M
71,251,083
9.86%
$2.88B
−17.5%
VIKING GLOBAL INVESTORS LP entity
10% owner
—
$128.70M (4)
−$128.70M
12,884,307
1.78%
$521.17M
−50.2%
VIKING GLOBAL PERFORMANCE LLC entity
10% owner
—
$128.70M (4)
−$128.70M
12,884,307
1.78%
$521.17M
−50.2%
Sukhatme Mayukh
President & CIO
—
$124.75M (17) scheduled
−$124.75M
18,630,739
2.58%
$753.61M
+515.9%
Torti Frank
President and Vant Chair
—
$82.04M (3) scheduled
−$82.04M
13,536,202
1.87%
$547.54M
—
Gline Matthew
CEO
$49.96K (1)
$71.78M (16) scheduled
−$71.73M
16,659,945
2.31%
$673.89M
+890.7%
Dexcel Pharma Technologies Ltd. entity
10% owner
$20.15M (3)
—
+$20.15M
102,849,443
14.24%
$4.16B
+4.1%
Kumar Rakhi
Chief Accounting Officer
—
$9.87M (25) scheduled
−$9.87M
162,306
0.0225%
$6.57M
−38.8%
Pulik Richard
CFO
—
$9.14M (3) scheduled
−$9.14M
271,810
0.0376%
$10.99M
+16.1%
Fitzgerald Meghan
Director
—
$3.27M (5) scheduled
−$3.27M
41,162
0.0057%
$1.67M
—
Epperly Melissa B,
Director
—
$2.01M (5)
−$2.01M
14,954
0.0021%
$604.89K
—
Humes Jennifer
Chief Accounting Officer
—
$384.07K (1)
−$384.07K
109,782
0.0152%
$4.44M
—
Oren Ilan
Director
—
—
—
123,680
0.0171%
$5.00M
—
MOMTAZEE JAMES C
Director
—
—
—
111,959
0.0155%
$4.53M
—
Lo Andrew
Director
—
—
—
52,142
0.0072%
$2.11M
—

Individual transactions

122
Insider
Date
Role
Action
Shares
Price
Amount
Fitzgerald Meghan
8 Sep 2026
Director
Sold after exercise
20,000
$39.90
$798.00K
Venker Eric
28 Aug 2026
President & Immunovant CEO
Sold after exercise
33,818
$36.44
$1.23M
Venker Eric
28 Aug 2026
President & Immunovant CEO
Sold after exercise
166,182
$35.63
$5.92M
Sukhatme Mayukh
21 Aug 2026
President & CIO
Sold after exercise
144,756
$36.48
$5.28M
Sukhatme Mayukh
20 Aug 2026
President & CIO
Sold after exercise
17,519
$37.30
$653.46K
Sukhatme Mayukh
19 Aug 2026
President & CIO
Sold after exercise
172,899
$37.17
$6.43M
Sukhatme Mayukh
18 Aug 2026
President & CIO
Sold after exercise
31,801
$37.18
$1.18M
Sukhatme Mayukh
18 Aug 2026
President & CIO
Sold after exercise
105,141
$36.59
$3.85M
Sukhatme Mayukh
17 Aug 2026
President & CIO
Sold after exercise
284,707
$36.25
$10.32M
Sukhatme Mayukh
14 Aug 2026
President & CIO
Sold after exercise
243,177
$36.23
$8.81M
Venker Eric
27 Jul 2026
President & Immunovant CEO
Sold after exercise
200,000
$34.95
$6.99M
Fitzgerald Meghan
30 Jun 2026
Director
Sold after exercise
10,000
$34.90
$349.00K
Epperly Melissa B,
29 Jun 2026
Director
Sold after exercise
2,748
$34.71
$95.38K
Epperly Melissa B,
29 Jun 2026
Director
Sold after exercise
15,002
$34.32
$514.87K
Sukhatme Mayukh
26 Jun 2026
President & CIO
Sold after exercise
500,000
$34.08
$17.04M
Sukhatme Mayukh
25 Jun 2026
President & CIO
Sold after exercise
500,000
$34.13
$17.07M
Venker Eric
24 Jun 2026
President & Immunovant CEO
Sold after exercise
46,234
$33.51
$1.55M
Venker Eric
24 Jun 2026
President & Immunovant CEO
Sold after exercise
153,766
$33.05
$5.08M
Venker Eric
22 May 2026
President & Immunovant CEO
Sold after exercise
200,000
$30.27
$6.05M
Venker Eric
20 Apr 2026
President & Immunovant CEO
Sold after exercise
200,000
$29.59
$5.92M
Fitzgerald Meghan
26 Mar 2026
Director
Sold after exercise
70,000
$27.45
$1.92M
Venker Eric
17 Mar 2026
President & Immunovant CEO
Sold after exercise
200,000
$28.24
$5.65M
Torti Frank
23 Feb 2026
President and Vant Chair
Sold after exercise
587,390
$27.51
$16.16M
Torti Frank
20 Feb 2026
President and Vant Chair
Sold after exercise
1,012,610
$27.15
$27.49M
Torti Frank
19 Feb 2026
President and Vant Chair
Sold after exercise
1,400,000
$27.42
$38.39M
Venker Eric
13 Feb 2026
President & Immunovant CEO
Sold after exercise
200,000
$26.49
$5.30M
Sukhatme Mayukh
9 Feb 2026
President & CIO
Sold after exercise
339,441
$26.47
$8.99M
Venker Eric
12 Jan 2026
President & Immunovant CEO
Sold after exercise
200,000
$21.92
$4.38M
Sukhatme Mayukh
31 Dec 2025
President & CIO
Sold after exercise
1,018,995
$21.71
$22.12M
Sukhatme Mayukh
29 Dec 2025
President & CIO
Sold after exercise
311,873
$21.74
$6.78M
Venker Eric
24 Dec 2025
President & Immunovant CEO
Sold after exercise
75,000
$22.53
$1.69M
Venker Eric
23 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$22.45
$4.49M
Pulik Richard
23 Dec 2025
CFO
Sold after exercise
146,731
$22.39
$3.29M
Pulik Richard
23 Dec 2025
CFO
Sold after exercise
260,000
$22.45
$5.84M
Sukhatme Mayukh
17 Dec 2025
President & CIO
Sold after exercise
26,831
$23.09
$619.53K
Ramaswamy Vivek
15 Dec 2025
10% owner
Sold after exercise
353,745
$22.05
$7.80M
Gline Matthew
15 Dec 2025
CEO
Sold after exercise
943,527
$21.68
$20.46M
Gline Matthew
15 Dec 2025
CEO
Sold after exercise
566,116
$21.68
$12.27M
Gline Matthew
15 Dec 2025
CEO
Sold after exercise
230,357
$21.68
$4.99M
Ramaswamy Vivek
12 Dec 2025
10% owner
Sold after exercise
1,975,858
$21.96
$43.39M
Ramaswamy Vivek
11 Dec 2025
10% owner
Sold after exercise
774,142
$21.64
$16.75M
Venker Eric
9 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.85
$4.17M
Venker Eric
7 Nov 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.22
$4.04M
Venker Eric
17 Oct 2025
President & Immunovant CEO
Sold after exercise
118,418
$17.06
$2.02M
Venker Eric
16 Oct 2025
President & Immunovant CEO
Sold after exercise
318,282
$17.05
$5.43M
Venker Eric
15 Oct 2025
President & Immunovant CEO
Sold after exercise
414,683
$16.93
$7.02M
Venker Eric
13 Oct 2025
President & Immunovant CEO
Sold after exercise
20,727
$16.25
$336.81K
Venker Eric
9 Oct 2025
President & Immunovant CEO
Sold after exercise
104,940
$16.30
$1.71M
Venker Eric
8 Oct 2025
President & Immunovant CEO
Sold after exercise
138,602
$16.20
$2.25M
Venker Eric
7 Oct 2025
President & Immunovant CEO
Sold after exercise
355,161
$16.15
$5.74M
Venker Eric
6 Oct 2025
President & Immunovant CEO
Sold after exercise
171,396
$16.34
$2.80M
Venker Eric
22 Sep 2025
President & Immunovant CEO
Sold after exercise
100,000
$15.01
$1.50M
Venker Eric
22 Sep 2025
President & Immunovant CEO
Sold after exercise
316,182
$14.99
$4.74M
Venker Eric
19 Sep 2025
President & Immunovant CEO
Sold after exercise
683,818
$14.95
$10.22M
Venker Eric
20 Aug 2025
President & Immunovant CEO
Sold after exercise
100,000
$11.72
$1.17M
Venker Eric
21 Jul 2025
President & Immunovant CEO
Sold after exercise
100,000
$11.52
$1.15M
Venker Eric
20 Jun 2025
President & COO
Sold after exercise
100,000
$11.45
$1.15M
Venker Eric
3 Jun 2025
President & COO
Sold after exercise
566,278
$11.22
$6.35M
Venker Eric
2 Jun 2025
President & COO
Sold after exercise
433,722
$11.07
$4.80M
Venker Eric
20 May 2025
President & COO
Sold after exercise
100,000
$10.95
$1.10M
Venker Eric
21 Apr 2025
President & COO
Sold after exercise
100,000
$10.22
$1.02M
Venker Eric
24 Mar 2025
President & COO
Sold after exercise
434,478
$10.82
$4.70M
Venker Eric
20 Mar 2025
President & COO
Sold after exercise
315,522
$11.06
$3.49M
Venker Eric
20 Feb 2025
President & COO
Sold after exercise
100,000
$10.65
$1.07M
Venker Eric
13 Feb 2025
President & COO
Sold after exercise
218,041
$10.42
$2.27M
Kumar Rakhi
13 Feb 2025
Chief Accounting Officer
Sold after exercise
227,500
$10.43
$2.37M
Venker Eric
12 Feb 2025
President & COO
Sold after exercise
217,384
$10.53
$2.29M
Venker Eric
21 Jan 2025
President & COO
Sold after exercise
100,000
$11.28
$1.13M
Venker Eric
30 Dec 2024
President & COO
Sold after exercise
177,704
$11.54
$2.05M
Venker Eric
27 Dec 2024
President & COO
Sold after exercise
176,900
$11.82
$2.09M
Sukhatme Mayukh
26 Dec 2024
Pres&Chief Investment Officer
Sold after exercise
689,495
$12.01
$8.28M
Sukhatme Mayukh
24 Dec 2024
Pres&Chief Investment Officer
Sold after exercise
185,946
$12.00
$2.23M
Sukhatme Mayukh
23 Dec 2024
Pres&Chief Investment Officer
Sold after exercise
10,796
$12.00
$129.55K
Venker Eric
20 Dec 2024
President & COO
Sold after exercise
100,000
$11.49
$1.15M
Sukhatme Mayukh
18 Dec 2024
Pres&Chief Investment Officer
Sold after exercise
412,584
$12.05
$4.97M
Venker Eric
20 Nov 2024
President & COO
Sold after exercise
100,000
$11.32
$1.13M
Venker Eric
21 Oct 2024
President & COO
Sold after exercise
100,000
$11.65
$1.17M
Kumar Rakhi
23 Sep 2024
Chief Accounting Officer
Sold after exercise
250,000
$11.89
$2.97M
Gline Matthew
23 Sep 2024
CEO
Sold after exercise
1,983,257
$11.79
$23.38M
Venker Eric
9 Feb 2024
President & COO
Sold after exercise
96,950
$10.92
$1.06M
Venker Eric
3 Oct 2023
Chief Operating Officer
Sold after exercise
606,221
$10.25
$6.21M
Venker Eric
2 Oct 2023
Chief Operating Officer
Sold after exercise
440,752
$10.80
$4.76M
Venker Eric
27 Sep 2023
President & COO
Sold after exercise
500,000
$13.02
$6.51M
Kumar Rakhi
8 Sep 2023
Chief Accounting Officer
Sold after exercise
99,350
$12.18
$1.21M
Venker Eric
8 Sep 2023
Chief Operating Officer
Sold after exercise
106,430
$12.19
$1.30M
Venker Eric
6 Sep 2023
Chief Operating Officer
Sold after exercise
5,926
$11.85
$70.22K
Venker Eric
5 Sep 2023
Chief Operating Officer
Sold after exercise
73,275
$11.92
$873.44K
Kumar Rakhi
5 Sep 2023
Chief Accounting Officer
Sold after exercise
1,724
$12.00
$20.69K
Venker Eric
1 Sep 2023
Chief Operating Officer
Sold after exercise
14,763
$11.90
$175.68K
Venker Eric
14 Aug 2023
Chief Operating Officer
Sold after exercise
59,811
$11.89
$711.15K
Kumar Rakhi
3 Aug 2023
Chief Accounting Officer
Sold after exercise
3,681
$12.00
$44.17K
Venker Eric
3 Aug 2023
Chief Operating Officer
Sold after exercise
44,629
$11.93
$532.42K
Venker Eric
2 Aug 2023
Chief Operating Officer
Sold after exercise
16,397
$11.86
$194.47K
Venker Eric
1 Aug 2023
Chief Operating Officer
Sold after exercise
61,397
$11.92
$731.85K
Kumar Rakhi
1 Aug 2023
Chief Accounting Officer
Sold after exercise
336
$12.00
$4.03K
Venker Eric
31 Jul 2023
Chief Operating Officer
Sold after exercise
117,372
$11.91
$1.40M
Venker Eric
27 Jul 2023
Chief Operating Officer
Sold after exercise
23,622
$10.98
$259.37K
Venker Eric
26 Jul 2023
Chief Operating Officer
Sold after exercise
73,568
$10.91
$802.63K
Venker Eric
25 Jul 2023
Chief Operating Officer
Sold after exercise
28,344
$10.86
$307.82K
Venker Eric
24 Jul 2023
President & COO
Sold after exercise
33,081
$10.93
$361.58K
Venker Eric
21 Jul 2023
President & COO
Sold after exercise
181,998
$11.13
$2.03M
Venker Eric
20 Jul 2023
President & COO
Sold after exercise
159,387
$11.31
$1.80M
Kumar Rakhi
18 Jul 2023
Chief Accounting Officer
Sold after exercise
100
$12.00
$1.20K
Kumar Rakhi
14 Jul 2023
Chief Accounting Officer
Sold after exercise
535
$12.00
$6.42K
Venker Eric
9 Jun 2023
President & COO
Sold after exercise
299,384
$9.91
$2.97M
Kumar Rakhi
9 Jun 2023
Chief Accounting Officer
Sold after exercise
43,893
$9.93
$435.86K
Venker Eric
7 Jun 2023
President & COO
Sold after exercise
201
$9.85
$1.98K
Venker Eric
23 May 2023
President & COO
Sold after exercise
415
$9.85
$4.09K
Venker Eric
9 May 2023
President & COO
Sold after exercise
238,724
$9.23
$2.20M
Venker Eric
8 May 2023
President & COO
Sold after exercise
61,206
$8.93
$546.57K
Venker Eric
4 May 2023
President & COO
Sold after exercise
88,838
$8.30
$737.36K
Venker Eric
3 May 2023
President & COO
Sold after exercise
118,760
$8.40
$997.58K
Kumar Rakhi
2 May 2023
Chief Accounting Officer
Sold after exercise
15,517
$8.42
$130.65K
Venker Eric
2 May 2023
President & COO
Sold after exercise
109,074
$8.29
$904.22K
Kumar Rakhi
1 May 2023
Chief Accounting Officer
Sold after exercise
62,219
$8.58
$533.84K
Venker Eric
1 May 2023
President & COO
Sold after exercise
61,155
$8.59
$525.32K
Venker Eric
28 Apr 2023
President & COO
Sold after exercise
75,823
$8.47
$642.22K
Kumar Rakhi
28 Apr 2023
Chief Accounting Officer
Sold after exercise
71,989
$8.47
$609.75K
Venker Eric
27 Apr 2023
President & COO
Sold after exercise
73,514
$8.51
$625.60K
Kumar Rakhi
27 Apr 2023
Chief Accounting Officer
Sold after exercise
70,969
$8.51
$603.95K
Venker Eric
26 Apr 2023
President & COO
Sold after exercise
72,906
$8.66
$631.37K
Kumar Rakhi
26 Apr 2023
Chief Accounting Officer
Sold after exercise
87,830
$8.68
$762.36K
Showing 250 of 297 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 425
Amendments (4/A) skipped 0
Filings about a different issuer 34
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 122
Sales at will 164
Transactions with no price 0
Shares from compensation/vesting 352,755,787
Sales filed before the plan box existed 53
History held since 17 Oct 2017